RaDiCo, the French national research program on rare disease cohorts - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Orphanet Journal of Rare Diseases Année : 2021

RaDiCo, the French national research program on rare disease cohorts

Résumé

Background: Rare diseases (RDs) affect nearly 3 million people in France and at least 26-30 million people in Europe. These diseases, which represent a major medical concern, are mainly of genetic origin, often chronic, progressive, degenerative, life threatening and disabling, accounting for more than one third of all deaths occurring during infancy. In this context, there are needs for coordinated information on RDs at national/international levels, based on high quality, interoperable and sharable data. The main objective of the RaDiCo (Rare Disease Cohorts) program, coordinated by Inserm, was the development of RD e-cohorts via a national platform. The cohort projects were selected through a national call in 2014. The e-cohorts are supported by an interoperable platform, equivalent to an infrastructure, constructed on the "cloud computing" principle and in compliance with the European General Data Protection Regulation. It is dedicated to allow a continuous monitoring of data quality and consistency, in line with the French Health Data Hub. Results: Depending on cohorts, the objectives are to describe the natural history of the studied RD(s), identify the underlying disease genes, establish phenotype-genotype correlations, decipher their pathophysiology, assess their societal and medico-economic impact, and/or identify patients eligible for new therapeutic approaches. Inclusion of prevalent and incident cases started at the end of 2016. As of April 2021, 5558 patients have been included within 13 RD e-cohorts covering 67 diseases integrated in 10 European Reference Networks and contributing to the European Joint Program on RDs. Several original results have been obtained in relation with the secondary objectives of the RaDiCo cohorts. They deal with discovery of new disease genes, assessment of treatment management, deciphering the underlying pathophysiological mechanisms, diagnostic approaches, genotype-phenotype relationships, development and validation of questionnaires relative to disease burden, or methodological aspects. Conclusion: RaDiCo currently hosts 13 RD e-cohorts on a sharable and interoperable platform constructed on the "cloud computing" principle. New RD e-cohorts at the European and international levels are targeted.
Fichier principal
Vignette du fichier
s13023-021-02089-5.pdf (1.21 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03420607 , version 1 (09-11-2021)

Identifiants

Citer

Serge Amselem, Sonia Gueguen, Jérôme Weinbach, Annick Clement, Paul Landais. RaDiCo, the French national research program on rare disease cohorts. Orphanet Journal of Rare Diseases, 2021, 16 (1), ⟨10.1186/s13023-021-02089-5⟩. ⟨hal-03420607⟩
61 Consultations
32 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More